Posted 9/11/2009 1:02 AM (GMT 0)
Here is my question for the top doctor:
1. Several opioid peptides are produced from milk and wheat protein digestion. Increased µ-opioid receptor (MOR) expression is seen on T cells that induce the inflammation associated with Crohn’s disease and ulcerative colitis.
Recent work in understanding the different result from digesting different casein has indicated higher disease (not neceassarly crohns) in particular casein variants. Proteins in bovine milk are a common source of bioactive peptides. The peptides are released by the digestion of caseins and whey proteins. In vitro the bioactive peptide beta-casomorphin 7 (BCM-7) is yielded by the successive gastrointestinal proteolytic digestion of bovine beta-casein variants A1 and B, but this was not seen in variant A2. In hydrolysed milk with variant A1 of beta-casein, BCM-7 level is 4-fold higher than in A2 milk.
Since there is increased µ-opioid receptor (MOR) expression, generally for crohns, does this indicate a problem with the mechanism of digestion of protein, particularly, casein in crohns patients, more specifically, can the increase be related to the known differences in casein variants.
2. If so, what should the prescribed medication be? An opoid antagonist such as cyprodime? Or a narcotic such as codeine, or narcotic-like drug such as lomotil?
3. Or is this question irrelevant.. as there is no relationship between protein digestion and inflammation in crohns.